The U.S. Food and Drug Administration on Nov. 8 approved a new oral medicine called Fruzaqla (fruquintinib) for the treatment of patients with previously treated metastatic colorectal cancer. Read More in FOX News. Read More in Red Pill NOWlej.
The U.S. Food and Drug Administration on Nov. 8 approved a new oral medicine called Fruzaqla (fruquintinib) for the treatment of patients with previously treated metastatic colorectal cancer. Read More in FOX News. Read More in Red Pill NOWlej.
